Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Department of Oncology, the Sidney Kimmel Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Clin Cancer Res. 2024 Feb 1;30(3):600-615. doi: 10.1158/1078-0432.CCR-23-0932.
Serous tubal intraepithelial carcinoma (STIC) is now recognized as the main precursor of ovarian high-grade serous carcinoma (HGSC). Other potential tubal lesions include p53 signatures and tubal intraepithelial lesions. We aimed to investigate the extent and pattern of aneuploidy in these epithelial lesions and HGSC to define the features that characterize stages of tumor initiation and progression.
We applied RealSeqS to compare genome-wide aneuploidy patterns among the precursors, HGSC (cases, n = 85), and histologically unremarkable fallopian tube epithelium (HU-FTE; control, n = 65). On the basis of a discovery set (n = 67), we developed an aneuploidy-based algorithm, REAL-FAST (Repetitive Element AneupLoidy Sequencing Fallopian Tube Aneuploidy in STIC), to correlate the molecular data with pathology diagnoses. We validated the result in an independent validation set (n = 83) to determine its performance. We correlated the molecularly defined precursor subgroups with proliferative activity and histology.
We found that nearly all p53 signatures lost the entire Chr17, offering a "two-hit" mechanism involving both TP53 and BRCA1 in BRCA1 germline mutation carriers. Proliferatively active STICs harbor gains of 19q12 (CCNE1), 19q13.2, 8q24 (MYC), or 8q arm, whereas proliferatively dormant STICs show 22q loss. REAL-FAST classified HU-FTE and STICs into 5 clusters and identified a STIC subgroup harboring unique aneuploidy that is associated with increased proliferation and discohesive growth. On the basis of a validation set, REAL-FAST showed 95.8% sensitivity and 97.1% specificity in detecting STIC/HGSC.
Morphologically similar STICs are molecularly distinct. The REAL-FAST assay identifies a potentially "aggressive" STIC subgroup harboring unique DNA aneuploidy that is associated with increased cellular proliferation and discohesive growth. REAL-FAST offers a highly reproducible adjunct technique to assist the diagnosis of STIC lesions.
输卵管上皮内浆液性癌(STIC)现在被认为是卵巢高级别浆液性癌(HGSC)的主要前体。其他潜在的输卵管病变包括 p53 特征和输卵管上皮内病变。我们旨在研究这些上皮病变和 HGSC 中染色体非整倍体的程度和模式,以确定其特征,这些特征可表征肿瘤起始和进展的阶段。
我们应用 RealSeqS 比较了前体、HGSC(病例,n=85)和组织学上无明显异常的输卵管上皮(HU-FTE;对照,n=65)之间的全基因组非整倍体模式。在一个发现集(n=67)的基础上,我们开发了一种基于非整倍性的算法,REAL-FAST(重复元件非整倍性测序在 STIC 中的输卵管非整倍性),将分子数据与病理诊断相关联。我们在一个独立的验证集(n=83)中验证了结果,以确定其性能。我们将分子定义的前体亚组与增殖活性和组织学相关联。
我们发现,几乎所有的 p53 特征都失去了整个 Chr17,这提供了一种涉及 BRCA1 种系突变的“两次打击”机制。增殖活跃的 STIC 具有 19q12(CCNE1)、19q13.2、8q24(MYC)或 8q 臂的增益,而增殖休眠的 STIC 则显示 22q 缺失。REAL-FAST 将 HU-FTE 和 STIC 分为 5 个簇,并鉴定出一个具有独特非整倍性的 STIC 亚组,该亚组与增殖增加和离散生长有关。基于验证集,REAL-FAST 在检测 STIC/HGSC 时显示出 95.8%的敏感性和 97.1%的特异性。
形态上相似的 STIC 在分子上是不同的。REAL-FAST 检测到一种具有独特 DNA 非整倍性的潜在“侵袭性”STIC 亚组,该亚组与细胞增殖增加和离散生长有关。REAL-FAST 提供了一种高度可重复的辅助技术,以协助 STIC 病变的诊断。